关键词: Biodesign Dialysis access Stanford device innovation need statement needs finding nephrology new devices unmet needs

Mesh : Hemodialysis Units, Hospital Humans Renal Dialysis

来  源:   DOI:10.1177/1129729820913692   PDF(Sci-hub)   PDF(Pubmed)

Abstract:
There is renewed demand to accelerate innovation in nephrology; public and private sectors are creating programs to support its growth. The Stanford Biodesign innovation process, first developed in 2000, provides a roadmap for health technology and device innovation. There is insufficient published guidance on the application of the Biodesign process in the generation of novel devices to address nephrology- and/or dialysis-related clinical unmet needs. We present \"needs finding,\" the initial part of the identify phase in the Biodesign innovation process and how it may be utilized for nephrology- and/or dialysis-related innovation. We describe here how to apply the Biodesign process to identify unmet dialysis-related needs, with the use of specific case-based examples based on observations within a hemodialysis unit. We then explore how to develop these needs using background research, direct clinical observations, interviews, documentation of observations and interview findings, and development of multiple needs statements. We conclude that there is an opportunity for nephrology innovators to use this methodology broadly in order to identify areas for innovation and initiated the development on novel solutions to be introduced into patient care.
摘要:
加快肾脏病学创新的新需求;公共和私营部门正在制定支持其增长的计划。斯坦福生物设计创新过程,于2000年首次开发,为卫生技术和设备创新提供了路线图。关于Biodesign过程在新型设备的生成中的应用,以解决与肾病和/或透析相关的临床未满足的需求,没有足够的公开指导。我们提出“需要寻找,“Biodesign创新过程中识别阶段的初始部分,以及如何将其用于肾病和/或透析相关的创新。我们在这里描述了如何应用Biodesign流程来识别未满足的透析相关需求,使用基于血液透析单位内观察的具体案例的例子。然后,我们利用背景研究探索如何发展这些需求,直接临床观察,采访,记录观察和访谈结果,并制定多种需求声明。我们得出的结论是,肾脏病学创新者有机会广泛使用这种方法,以确定创新领域,并开始开发新的解决方案,以引入患者护理。
公众号